Use of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation
Top Cited Papers
- 10 May 2001
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 344 (19) , 1411-1420
- https://doi.org/10.1056/nejm200105103441901
Abstract
The conventional treatment strategy for patients with atrial fibrillation who are to undergo electrical cardioversion is to prescribe warfarin for anticoagulation for three weeks before cardioversion. It has been proposed that if transesophageal echocardiography reveals no atrial thrombus, cardioversion may be performed safely after only a short period of anticoagulant therapy.Keywords
This publication has 35 references indexed in Scilit:
- Antithrombotic Therapy in Atrial FibrillationChest, 1998
- Management of Patients With Atrial FibrillationCirculation, 1996
- Management of Atrial Fibrillation in Adults: Prevention of Thromboembolism and Symptomatic TreatmentMayo Clinic Proceedings, 1996
- Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implicationsArchives of internal medicine (1960), 1995
- Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation?Journal of the American College of Cardiology, 1994
- Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombusJournal of the American College of Cardiology, 1986
- Coronary heart disease and atrial fibrillation: The Framingham StudyAmerican Heart Journal, 1983
- The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillationThe American Journal of Cardiology, 1969
- Electrical reversion of cardiac arrhythmias.Heart, 1967
- Electrocardiographic Findings Among the Adult Population of a Total Natural Community, Tecumseh, MichiganCirculation, 1965